BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

108 related articles for article (PubMed ID: 2868381)

  • 1. Circulating somatostatin concentrations in healthy and cirrhotic subjects.
    Verrillo A; de Teresa A; Martino C; Pinto M; Golia R
    Metabolism; 1986 Feb; 35(2):130-5. PubMed ID: 2868381
    [TBL] [Abstract][Full Text] [Related]  

  • 2. Plasma somatostatin response to an oral mixed test meal in cirrhotic patients.
    Barreca T; Franceschini R; Cataldi A; Rolandi E
    J Hepatol; 1991 Jan; 12(1):40-4. PubMed ID: 1672540
    [TBL] [Abstract][Full Text] [Related]  

  • 3. Glucagon and glucose tolerance in liver cirrhosis.
    Greco AV; Altomonte L; Ghirlanda G; D'Anna LM; Manna R; Caputo S; Uccioli L
    Acta Endocrinol (Copenh); 1988 Jul; 118(3):337-45. PubMed ID: 2899368
    [TBL] [Abstract][Full Text] [Related]  

  • 4. Prandial regulation of ghrelin secretion in humans: does glucagon contribute to the preprandial increase in circulating ghrelin?
    Soule S; Pemberton C; Hunt P; Cole D; Raudsepp S; Inder W
    Clin Endocrinol (Oxf); 2005 Oct; 63(4):412-7. PubMed ID: 16181233
    [TBL] [Abstract][Full Text] [Related]  

  • 5. Failure of glucagon to stimulate hepatic glycogenolysis in well-nourished patients with mild cirrhosis.
    Petrides AS; De Fronzo RA
    Metabolism; 1994 Jan; 43(1):85-9. PubMed ID: 8289679
    [TBL] [Abstract][Full Text] [Related]  

  • 6. Diurnal variations in plasma insulin concentrations in normal and cirrhotic subjects: effect of dietary protein.
    Fernstrom JD; Arnold MA; Wurtman RJ; Hammarstrom-Wiklund B; Munro HN; Davidson CS
    J Neural Transm Suppl; 1978; (14):133-42. PubMed ID: 290734
    [TBL] [Abstract][Full Text] [Related]  

  • 7. Elevated growth hormone levels and insulin resistance in patients with cirrhosis of the liver.
    Shankar TP; Fredi JL; Himmelstein S; Solomon SS; Duckworth WC
    Am J Med Sci; 1986 Apr; 291(4):248-54. PubMed ID: 3518447
    [TBL] [Abstract][Full Text] [Related]  

  • 8. Glucose kinetics and splanchnic uptake following mixed meal ingestion in cirrhotic-diabetic subjects.
    Kiwanuka E; Barazzoni R; Tessari P
    Diabetes Nutr Metab; 2001 Dec; 14(6):315-24. PubMed ID: 11853363
    [TBL] [Abstract][Full Text] [Related]  

  • 9. Insulin, C-peptide and glucagon levels during OGTT in hepatic cirrhosis and in patients with prehepatic block.
    Gerö L; Korányi L; Szalay F; Büki B; Tamás G
    Acta Diabetol Lat; 1982; 19(1):55-64. PubMed ID: 7041501
    [TBL] [Abstract][Full Text] [Related]  

  • 10. Hyperglucagonemia in liver cirrhosis with portal-systemic venous anastomoses: responses of plasma glucagon and gastric inhibitory polypeptide to oral or intravenous glucose in cirrhotics with normal or elevated fasting plasma glucose levels.
    McDonald TJ; Dupre J; Caussignac Y; Radziuk J; Van Vliet S
    Metabolism; 1979 Apr; 28(4):300-7. PubMed ID: 449682
    [TBL] [Abstract][Full Text] [Related]  

  • 11. Elevated plasma ammonia level in hepatic cirrhosis: role of glucagon.
    Kabadi UM; Eisenstein AB; Konda J
    Gastroenterology; 1985 Mar; 88(3):750-6. PubMed ID: 3881308
    [TBL] [Abstract][Full Text] [Related]  

  • 12. Effect of physiologic hyperinsulinemia on glucose and lipid metabolism in cirrhosis.
    Petrides AS; Groop LC; Riely CA; DeFronzo RA
    J Clin Invest; 1991 Aug; 88(2):561-70. PubMed ID: 1864966
    [TBL] [Abstract][Full Text] [Related]  

  • 13. Evidence for an augmented glucagon dependence of hepatic glucose production in cirrhosis of the liver.
    Keller U; Sonnenberg GE; Burckhardt D; Perruchoud A
    J Clin Endocrinol Metab; 1982 May; 54(5):961-8. PubMed ID: 6120952
    [TBL] [Abstract][Full Text] [Related]  

  • 14. Hyperinsulinaemia and insulin resistance of cirrhosis: the importance of insulin hypersecretion.
    Proietto J; Dudley FJ; Aitken P; Alford FP
    Clin Endocrinol (Oxf); 1984 Dec; 21(6):657-65. PubMed ID: 6391746
    [TBL] [Abstract][Full Text] [Related]  

  • 15. Pancreatic beta-cell function in cirrhotic patients with and without overt diabetes. C-peptide response to glucagon and to meal.
    Marchesini G; Melli A; Checchia GA; Mattioli L; Capelli M; Cassarani S; Zoli M; Pisi E
    Metabolism; 1985 Aug; 34(8):695-701. PubMed ID: 3894876
    [TBL] [Abstract][Full Text] [Related]  

  • 16. Effect of somatostatin (SRIF) on plasma glucose and insulin response to glucagon in liver cirrhosis.
    Altomonte L; Greco AV; Ghirlanda G; Rebuzzi AG; Manna R; Bertoli A
    Acta Diabetol Lat; 1979; 16(2):139-45. PubMed ID: 484163
    [TBL] [Abstract][Full Text] [Related]  

  • 17. Glucose intolerance in thyrotoxicosis roles of insulin, glucagon and somatostatin.
    Lam KS; Yeung RT; Ho PW; Lam SK
    Acta Endocrinol (Copenh); 1987 Feb; 114(2):228-34. PubMed ID: 2881418
    [TBL] [Abstract][Full Text] [Related]  

  • 18. Hyperglucagonemia in cirrhosis: altered secretion and sensitivity to glucagon.
    Sherwin RS; Fisher M; Bessoff J; Snyder N; Hendler R; Conn HO; Felig P
    Gastroenterology; 1978 Jun; 74(6):1224-8. PubMed ID: 648812
    [TBL] [Abstract][Full Text] [Related]  

  • 19. Hormone and metabolite profiles in alcoholic liver disease.
    Stewart A; Johnston DG; Alberti KG; Nattrass M; Wright R
    Eur J Clin Invest; 1983 Oct; 13(5):397-403. PubMed ID: 6416854
    [TBL] [Abstract][Full Text] [Related]  

  • 20. Oral glucose in cirrhotics. Effects on plasma aminoacid patterns and the role of insulin and glucagon.
    Marchesini G; Forlani G; Angiolini A; Zoli M; Scolari MP; Bianchi FB; Pisi E
    Diabete Metab; 1979 Jun; 5(2):135-9. PubMed ID: 478083
    [TBL] [Abstract][Full Text] [Related]  

    [Next]    [New Search]
    of 6.